Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections

PHASE3TerminatedINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2008

Conditions

Skin Diseases, InfectiousSoft Tissue Infections

Interventions

DRUG

Daptomycin

4 mg/kg intravenous once daily

DRUG

Vancomycin

1 g intravenous twice daily

DRUG

Teicoplanin

400 mg intravenous once daily following a loading dose of 400 mg administered at 0, 12, 24 hours on day one.